Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
S M de Morais, P G Wells

Abstract

Glucuronidation is the major pathway for elimination of acetaminophen, diverting it from the toxifying pathway catalyzed by cytochromes P-450. A genetic deficiency in bilirubin UDP-glucuronyl transferase may predispose humans and animals to the toxicity of drugs that are extensively glucuronidated, if other glucuronyl transferase isoenzymes are concurrently deficient. Homozygous and heterozygous Gunn rats are, respectively, severely and moderately deficient in glucuronyl transferase. Acetaminophen (500 mg per kg) was administered intraperitoneally to homozygous and heterozygous Gunn rats and to Wistar controls. Hepatic and renal cellular damage was assessed by peak plasma concentrations of ALT and blood urea nitrogen, respectively. Homozygous and heterozygous Gunn rats showed, respectively, 115-fold and 9-fold higher ALT concentrations compared to Wistar controls. Blood urea nitrogen was elevated only in the homozygous Gunn rats (3-fold). Biotransformation of acetaminophen was measured by high-performance liquid chromatography. Acetaminophen glucuronidation was decreased by 72 and 35% (p less than 0.05), respectively, in the homozygous and heterozygous Gunn rats compared with Wistar controls. Production of acetaminophen glucuro...Continue Reading

References

May 31, 1978·European Journal of Clinical Pharmacology·A P DouglasM D Rawlins
Jun 1, 1987·European Journal of Clinical Investigation·D UllrichJ Bircher
Jul 1, 1986·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·P G Wells, E C To
Feb 1, 1971·Journal of Pharmaceutical Sciences·G Levy, H Yamada
Oct 1, 1980·British Journal of Clinical Pharmacology·L F Prescott
Oct 1, 1981·Pathology·I C CalderJ D Tange
Jun 25, 1959·The New England Journal of Medicine·R SCHMID, L HAMMAKER

❮ Previous
Next ❯

Citations

Jul 21, 1999·European Journal of Drug Metabolism and Pharmacokinetics·A Esteban, M Pérez-Mateo
Mar 7, 2013·Pharmaceutical Research·Mitchell R McGill, Hartmut Jaeschke
Jun 1, 1997·Environmental Health Perspectives·B Burchell, M W Coughtrie
Oct 10, 2007·Clinical Pharmacokinetics·Darren M Roberts, Nick A Buckley
Apr 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nikhil K BasuIda S Owens
Jan 6, 2006·Drug Metabolism Reviews·P David Josephy
Jun 2, 2007·Expert Opinion on Drug Metabolism & Toxicology·Wei Tang
Nov 21, 2014·Drug Metabolism Reviews·Deepak DalvieWeichao Chen
Jan 18, 2011·British Journal of Clinical Pharmacology·Yong LiuMark J Ratain
Jun 1, 1993·Journal of Hepatology·A Esteban, M Pérez-Mateo
Apr 15, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yuchao XieHartmut Jaeschke
Jan 10, 2006·Methods in Enzymology·Nandita ShangariPeter J O'Brien
Apr 28, 2017·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Anselm Wong, Andis Graudins
Jan 1, 1997·Journal of Hepatology·J Reichen
May 15, 2002·Addiction Biology·Stephen M Riordan, Roger Williams
Jun 10, 2006·The Journal of Pharmacology and Experimental Therapeutics·Kristini K MilesJoseph K Ritter
Feb 21, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Fay K KesslerJoseph K Ritter
Feb 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Peter G WellsJoseph K Ritter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.